Test-Makers See Way Out Of FDA Rule With Chevron Reversal
This spring, despite widespread industry opposition, the U.S. Food and Drug Administration granted itself oversight of laboratory-developed diagnostic tests. Now, industry groups say they're facing a costly and convoluted agency approval...To view the full article, register now.
Already a subscriber? Click here to view full article